Pancreatic Cancer Research

ResearcherCentre Hospitalier Universitaire de ReimsActive in the last 2 years

Tullio Piardi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6704-3206; OpenAlex author ID A5048744014. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 8

  1. Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and urine: A targeted-screening analysis ca… Co-author DOI 10.1002/ueg2.12602↗
  2. Multi-visceral resection for left-sided pancreatic ductal adenocarcinoma: a multicenter retrospective analysis from European countries. Co-author DOI 10.1007/s00423-023-03110-0↗
  3. Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective obs… Co-author DOI 10.1016/j.ejca.2022.01.040↗
  4. Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival? Last author DOI 10.3389/fonc.2022.980659↗
  5. Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma. Co-author DOI 10.1186/s12893-021-01409-7↗
  6. The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospecti… Co-author DOI 10.1245/s10434-020-09310-y↗
  7. Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers11111718↗
  8. The density of mast cells c-Kit+ and tryptase+ correlates with each other and with angiogenesis in pancreatic cancer patients. Co-author DOI 10.18632/oncotarget.19716↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mathias Brügel · 4 shared papers, 2021–2024 · strength 0.56
  2. Olivier Bouché · 4 shared papers, 2021–2024 · strength 0.56
  3. Patrick Pessaux · 4 shared papers, 2017–2023 · strength 0.43
  4. Riccardo Memeo · 3 shared papers, 2017–2023 · strength 0.30
  5. Mircea Chirica · 2 shared papers, 2021–2023 · strength 0.25
  6. Fabrizio Panaro · 2 shared papers, 2021–2023 · strength 0.25
  7. Piera Leon · 2 shared papers, 2021–2023 · strength 0.25
  8. Laurent Sulpice · 2 shared papers, 2021–2023 · strength 0.25
  9. Ugo Boggi · 2 shared papers, 2021–2023 · strength 0.25
  10. Massimo Falconi · 2 shared papers, 2021–2023 · strength 0.25
  11. Marine Perrier · 1 shared paper, 2024 · strength 0.20
  12. Michele Ammendola · 2 shared papers, 2017–2019 · strength 0.15
  13. Edoardo Rosso · 1 shared paper, 2023 · strength 0.15
  14. Cecilia Ferrari · 1 shared paper, 2023 · strength 0.15
  15. Violette Fossaert · 1 shared paper, 2022 · strength 0.15
  16. Cindy Neuzillet · 1 shared paper, 2021 · strength 0.12
  17. Sophie Deguelte · 1 shared paper, 2021 · strength 0.12
  18. Christelle d’Engremont · 1 shared paper, 2022 · strength 0.11
  19. Frédéric Di Fiore · 1 shared paper, 2022 · strength 0.11
  20. Gaël S. Roth · 1 shared paper, 2022 · strength 0.11
  21. Lilian Schwarz · 1 shared paper, 2022 · strength 0.11
  22. Mehdi El Amrani · 1 shared paper, 2022 · strength 0.11
  23. Christophe Borg · 1 shared paper, 2022 · strength 0.11
  24. Anthony Turpin · 1 shared paper, 2022 · strength 0.11
  25. Stéphanie Truant · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.